O.PE.R.A. BREAST - ONCOLOGY PROFESSIONAL REMOTE ACADEMY

1. 1.Rastogi. J. Adjuvant Abema in high-risk HR+/HER2-: MonarchE trial. Clin Oncol. 2024
   Adjuvant Abema in high-risk HR+/HER2-: MonarchE trial
   LibroCerca su Amazon
2. 2.Rastogi. J. iDFS in ITT Population at Median Follow-up of 4.5 Yr. Clin Oncol. 2024
   iDFS in ITT Population at Median Follow-up of 4.5 Yr
   LibroCerca su Amazon
3. 3.O'Shaughnessy J et al. Impact of dose reductions on efficacy of adjuvant abemaciclib for patients with high-risk EBC. ESMO. 2023
   Articolo scientificoESMOLeggi il PDF gratuito
4. 4.O'Shaughnessy J et al. Impact of dose reductions on efficacy of adjuvant abemaciclib for patients with high-risk EBC. ESMO. 2023
   Articolo scientificoESMOLeggi il PDF gratuito
5. 5.Slamon D. Adjuvant Ribo in intermediate/high-risk HR+/HER2-: NATALEE trial. NEJM. 2023
   Adjuvant Ribo in intermediate/high-risk HR+/HER2-: NATALEE trial
   LibroCerca su Amazon
6. 6.Arecco L et al. MonarchE and Natalee studies: Inclusion criteria. The Breast. 2024
   Articolo scientificoThe BreastCerca su Google Scholar
7. 7.Arecco L et al. GIM23 study: Proportion of patients considered at non-high-risk and high-risk of recurrence according to monarchE and NATALEE trials. The Breast. 2024
   Articolo scientificoThe BreastCerca su Google Scholar

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).